Eli Lilly's stock has surged 60% YTD due to strong demand for obesity drugs. Analysts predict more growth ahead with a potential stock split in 2024, expanding representation beyond tech sector.
Berenberg and JPMorgan analysts have set a price target of $1,000 for Eli Lilly stock, citing potential for further upside. Both analysts are bullish on the company's future performance and stock split prospects.
[
Collection
]
[
|
...
]